Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

255 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Compared Burden of Psoriasis, Atopic Dermatitis, Hidradenitis Suppurativa, and Chronic Urticaria: Baseline Characteristics of the Patients Included in the OMCCI Cohort - A French, Prospective Multicenter Study of Chronic Inflammatory Dermatoses.
Becherel PA, Reguiai Z, Fougerousse AC, Perrot JL, Begon E, Thomas-Beaulieu D, Mery-Bossard L, Pourchot D, Boulard C, Fite C, Beaziz J, Zaraa I, Lons-Danic D, Badaoui A, Parier J, Chaby G, Estève E, Liegeon AL, Patchinsky A, Muller P, Lepelley-Dupont C, Poreaux C, Jacobzone-Lévêque C, Chassain K, Mohty R, Perrussel M, Garcia C, Girard C, Dillies AS, Amy de la Breteque M, Quiles-Tsimaratos N, Denis D, Maccari F. Becherel PA, et al. Among authors: boulard c. Dermatology. 2024;240(5-6):702-712. doi: 10.1159/000540250. Epub 2024 Jul 17. Dermatology. 2024. PMID: 39019015
Evolution of dupilumab-associated conjunctivitis in patients with atopic dermatitis after switching dupilumab to tralokinumab or Janus kinase inhibitors (RESO-ADOC study).
Reguiai Z, Becherel PA, Perrot JL, Boulard C, Fougerousse AC, Begon E, Badaoui A, Poreaux C, Parier J, Liegeon AL, Levavasseur M, Bing AC, Estève E, Maccari F; GEM reso‐Dermatologie and OMCCI Group. Reguiai Z, et al. Among authors: boulard c. J Eur Acad Dermatol Venereol. 2024 Nov;38(11):2149-2155. doi: 10.1111/jdv.20233. Epub 2024 Jul 17. J Eur Acad Dermatol Venereol. 2024. PMID: 39015045
Clinical Characteristics and Therapeutic Management of Atopic Dermatitis in Elderly Patients Compared with Young Adult Patients: A Prospective Multicentre Study.
Pollyn-Millot C, Maccari F, Perrot JL, Reguiai Z, Boulard C, Becherel PA, Poreaux C, Mery-Bossard L, Beaulieu D, Pourchot D, Fougerousse AC, Begon E, Liegeon AL, Fite C, Zaraa I, Lons-Danic D, Walls B, Jacobzone C, Lepelley C, Denis D, Chaby G; OMCCI Group. Pollyn-Millot C, et al. Among authors: boulard c. Acta Derm Venereol. 2024 Sep 9;104:adv40420. doi: 10.2340/actadv.v104.40420. Acta Derm Venereol. 2024. PMID: 39248293 Free PMC article.
Impact of dupilumab on patch test results and allergic contact dermatitis: A prospective multicenter study.
Bocquel S, Soria A, Raison-Peyron N, Badaoui A, Marcant P, Bara C, Giordano-Labadie F, Amsler E, Milpied B, Delaunay J, Darrigade AS, Pralong P, Boulard C, Ferrier Le Bouedec MC, Tauber M, Pasteur J, Valois A, Le Thuaut A, Crépy MN, Bernier C. Bocquel S, et al. Among authors: boulard c. J Am Acad Dermatol. 2024 Mar;90(3):512-520. doi: 10.1016/j.jaad.2023.10.029. Epub 2023 Oct 21. J Am Acad Dermatol. 2024. PMID: 37871801
Impact of Baricitinib on Patients' Quality of Life after One Year of Treatment for Atopic Dermatitis in Real-World Practice: Results of the Observatory of Chronic Inflammatory Skin Diseases Registry.
Reguiai Z, Becherel PA, Perrot JL, Fougerousse AC, Begon E, Poreaux C, Boulard C, Chaby G, Fite C, Zaraa I, Lons-Danic D, Liegeon AL, Parier J, Quiles-Tsimaratos N, David L, Maccari F. Reguiai Z, et al. Among authors: boulard c. Acta Derm Venereol. 2023 Oct 6;103:adv14153. doi: 10.2340/actadv.v103.14153. Acta Derm Venereol. 2023. PMID: 37800349 Free PMC article.
[Erythema of the lower limb].
Loridon L, Langlois V, Boulard C. Loridon L, et al. Among authors: boulard c. Rev Med Interne. 2024 Jan;45(1):50-51. doi: 10.1016/j.revmed.2023.08.002. Epub 2023 Aug 23. Rev Med Interne. 2024. PMID: 37626002 French. No abstract available.
Epoxy resin, an emerging allergen in women?
Temam I, Bauvin O, Boulard C. Temam I, et al. Among authors: boulard c. Contact Dermatitis. 2023 Dec;89(6):503-505. doi: 10.1111/cod.14410. Epub 2023 Aug 23. Contact Dermatitis. 2023. PMID: 37611919 No abstract available.
Janus kinase inhibitors for the treatment of atopic dermatitis: Real-life data on efficacy and safety in light of the Pharmacovigilance Risk Assessment Committee recommended measures.
Reguiai Z, Becherel PA, Fougerousse AC, Chaby G, Perrot JL, Begon E, Jacobzone-Lévêque C, Boulard C, Badaoui A, Poreaux C, David L, Quiles-Tsimaratos N, Lons-Danic D, Fite C, Liegeon AL, Patchinsky A, Parier J, Garcia C, Estève E, Mohty R, Mery-Bossard L, Maccari F. Reguiai Z, et al. Among authors: boulard c. J Eur Acad Dermatol Venereol. 2023 Nov;37(11):e1307-e1309. doi: 10.1111/jdv.19302. Epub 2023 Jul 14. J Eur Acad Dermatol Venereol. 2023. PMID: 37415328 No abstract available.
What is the optimal duration for a ROAT? The experience of the French Dermatology and Allergology group (DAG).
Amsler E, Assier H, Soria A, Bara C, Ferrier le Bouëdec MC, Barbaud A, Milpied B, Giordano-Labadie F, Pasteur J, Badaoui A, Valois A, Castelain F, Kurihara F, Castagna J, Boulard C, Bernier C, Leleu C, Marcant P, Crépy MN, Tetart F, Raison-Peyron N; from the Dermatology and Allergy Group of the French Society of Dermatology (DAG). Amsler E, et al. Among authors: boulard c. Contact Dermatitis. 2022 Aug;87(2):170-175. doi: 10.1111/cod.14118. Epub 2022 Apr 15. Contact Dermatitis. 2022. PMID: 35383393
255 results